Biomarin Pharmaceutical
BMRNBioMarin Pharmaceutical Inc. is an American biotechnology company headquartered in San Rafael, California. It has offices and facilities in the United States, South America, Asia, and Europe. BioMarin's core business and research is in enzyme replacement therapies (ERTs). BioMarin was the first comp …
© Wikipedia /
Creative Commons CC-BY-SA 3.0 more at Wikipedia
Insider trades and stock quote 2024-2026
All insider trades at Biomarin Pharmaceutical
Subscribe RSS| Date | Type | Insider | Position | Ø-Price | Volume |
|---|---|---|---|---|---|
| 3/11/2026 | Sell | Guyer, Charles Greg | EVP, Chief Technical Officer | $60.5 | $996,744 |
| 2/26/2026 | Sell | Davis, George Eric | EVP, Chief Legal Officer | $61.4 | $1,599,103 |
| 2/26/2026 | Sell | Friberg, Gregory R. | EVP, Chief R&D Officer | $60.4 | $381,937 |
| 5/20/2025 | Sell | Burkhart, Erin | GVP, Chief Accounting Officer | $59.3 | $105,928 |
| 5/2/2025 | Sell | Hubbard, Cristin | EVP, Chief Commercial Officer | $64.9 | $17,723 |
All information without guarantee! No recommendation/consultation!
© U.S. Securities and Exchange Commission (SEC)